Persistent and Sasken have highly disappointed with results even with currency tailwinds. There is no excuse there to be buying/holding anymore and they have to revert to their historical valuations which means even their current prices are expensive. These are smallcaps and shouldn’t affect the index much. Some like TCS and Mphasis haven’t done badly (I don’t hold either). As always, am as much in as I am out so am varying parts bullish and bearish and my allocations reflect that. If it breaks 200 DMA, no more adding. I am looking to see if Sonata can be a value buy but will change my mind if results/dividend disappoints.
2 Likes